KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 63,090 Value ($000) $168 Avg Close — Range —
Q4 2023
Shares 156,226 Value ($000) $370 Avg Close — Range —
Q3 2023
Shares 78,971 Value ($000) $111 Avg Close — Range —
Q2 2023
Shares 159,005 Value ($000) $482 Avg Close — Range —
Q1 2023
Shares 219,517 Value ($000) $1,372 Avg Close — Range —
Q4 2022
Shares 72,038 Value ($000) $439 Avg Close — Range —
Q3 2022
Shares 199,788 Value ($000) $2 Avg Close — Range —
Q2 2022
Shares 210,958 Value ($000) $3 Avg Close — Range —
Q1 2022
Shares 68,154 Value ($000) $767 Avg Close — Range —
Q4 2021
Shares 57,067 Value ($000) $1,012 Avg Close — Range —
Q3 2021
Shares 94,561 Value ($000) $2,177 Avg Close — Range —
Q2 2021
Shares 15,212 Value ($000) $354 Avg Close — Range —
Q1 2021
Shares 17,774 Value ($000) $554 Avg Close — Range —
Q4 2020
Shares 60,286 Value ($000) $2,398 Avg Close — Range —